JIP
OPK icon

Jaffetilchin Investment Partners’s Opko Health OPK Stock Holding History

Jaffetilchin Investment Partners’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$1 – 994
2024
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 1357
2019
Q4 		– Sell
-33,500
Closed -$70K – 243
2019
Q3 		$70K Sell
33,500
-525
-2% -$1.07K 0.02% 213
2019
Q2 		$83K Hold
34,025
– – 0.02% 255
2019
Q1 		$89K Hold
34,025
– – 0.02% 283
2018
Q4 		$102K Sell
34,025
-1,275,110
-97% -$4.32M 0.03% 246
2018
Q3 		$4.53M Buy
1,309,135
+1,827
+0.1% +$9.7K 0.96% 22
2018
Q2 		$6.14M Sell
1,307,308
-8,042
-0.6% -$30.5K 1.37% 18
2018
Q1 		$4.17M Buy
1,315,350
+372,311
+39% +$1.5M 0.93% 22
2017
Q4 		$4.62M Sell
943,039
-128,018
-12% -$743K 1.54% 15
2017
Q3 		$7.35M Buy
1,071,057
+64,593
+6% +$407K 1.73% 11
2017
Q2 		$6.62M Buy
1,006,464
+353,104
+54% +$2.48M 2.24% 11
2017
Q1 		$5.23M Buy
653,360
+194,657
+42% +$1.64M 1.33% 16
2016
Q4 		$4.27M Buy
458,703
+30,358
+7% +$314K 1.27% 20
2016
Q3 		$4.54M Sell
428,345
-22,105
-5% -$220K 1.44% 17
2016
Q2 		$4.21M Buy
450,450
+5,182
+1% +$52.6K 1.28% 19
2016
Q1 		$4.63M Buy
445,268
+33,435
+8% +$305K 1.46% 19
2015
Q4 		$4.14M Buy
411,833
+45,982
+13% +$461K 1.34% 18
2015
Q3 		$3.08M Buy
365,851
+153,515
+72% +$2.03M 1.15% 18
2015
Q2 		$3.41M Buy
212,336
+1,386
+0.7% +$21.6K 1.02% 20
2015
Q1 		$2.99M Sell
210,950
-8,000
-4% -$104K 0.9% 21
2014
Q4 		$2.19M Buy
218,950
+5,075
+2% +$43.4K 0.73% 25
2014
Q3 		$1.82M Buy
213,875
+50,000
+31% +$439K 0.67% 23
2014
Q2 		$1.45M Buy
163,875
+3,375
+2% +$29.5K 0.52% 27
2014
Q1 		$1.5M Buy
160,500
+71,000
+79% +$622K 0.58% 31
2013
Q4 		$755K Buy
+89,500
New +$905K 0.37% 65

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jaffetilchin Investment Partners's OPK Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Opko Health (OPK) in Q4 2024, closing a stake of 1 share — an estimated $1 sold.

Jaffetilchin Investment Partners first reported a position in OPK in Q4 2013 and held it in 25 quarters. The position peaked at $7.35M in Q3 2017. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 1 Opko Health share in Q4 2024, an estimated $1.
  • Jaffetilchin Investment Partners first reported a position in Opko Health in Q4 2013 and held it in 25 quarters.
  • Jaffetilchin Investment Partners's Opko Health position peaked at $7.35M in Q3 2017.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.